ArticleClinical and experimental medicine2010

Higher pretherapy and significant decrease during the first 12 months of therapy in serum laminin levels may associate with hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with lamivudine.

Qunying Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.